
IceCure Medical Investor Relations Material
Latest events

Q4 2024
IceCure Medical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from IceCure Medical Ltd
Access all reports
IceCure Medical Ltd. is a commercial-stage medical device company that focuses on the development and marketing of cryoablation systems. Utilizing liquid nitrogen-based technology, the company offers minimally invasive treatments for both benign and malignant tumors, primarily targeting applications in women's health and interventional oncology. IceCure Medical's flagship product, the ProSense Cryoablation System, destroys tumors by freezing them, providing an alternative to traditional surgical tumor removal. IceCure Medical Ltd. is headquartered in Caesarea, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ICCM
Country
🇺🇸 United States